Suppr超能文献

基于碘乙酰胺和丙烯酰胺对半胱氨酸的差异烷基化的蛋白质定量质谱策略。

A Mass Spectrometry Strategy for Protein Quantification Based on the Differential Alkylation of Cysteines Using Iodoacetamide and Acrylamide.

机构信息

Department of Pharmaceutics, Semmelweis University, Hőgyes Endre utca 7., H-1092 Budapest, Hungary.

MTA-ELTE Lendület Ion Mobility Mass Spectrometry Research Group, Institute of Chemistry, Faculty of Science, ELTE Eötvös Loránd University, Pázmány Péter sétány 1/A, H-1117 Budapest, Hungary.

出版信息

Int J Mol Sci. 2024 Apr 25;25(9):4656. doi: 10.3390/ijms25094656.

Abstract

Mass spectrometry has become the most prominent yet evolving technology in quantitative proteomics. Today, a number of label-free and label-based approaches are available for the relative and absolute quantification of proteins and peptides. However, the label-based methods rely solely on the employment of stable isotopes, which are expensive and often limited in availability. Here we propose a label-based quantification strategy, where the mass difference is identified by the differential alkylation of cysteines using iodoacetamide and acrylamide. The alkylation reactions were performed under identical experimental conditions; therefore, the method can be easily integrated into standard proteomic workflows. Using high-resolution mass spectrometry, the feasibility of this approach was assessed with a set of tryptic peptides of human serum albumin. Several critical questions, such as the efficiency of labeling and the effect of the differential alkylation on the peptide retention and fragmentation, were addressed. The concentration of the quality control samples calculated against the calibration curves were within the ±20% acceptance range. It was also demonstrated that heavy labeled peptides exhibit a similar extraction recovery and matrix effect to light ones. Consequently, the approach presented here may be a viable and cost-effective alternative of stable isotope labeling strategies for the quantification of cysteine-containing proteins.

摘要

质谱分析已成为定量蛋白质组学中最突出且不断发展的技术。目前,有许多非标记和标记方法可用于相对和绝对蛋白质和肽的定量。然而,标记方法仅依赖于稳定同位素的使用,而这些同位素昂贵且通常供应有限。在这里,我们提出了一种基于标记的定量策略,其中通过碘乙酰胺和丙烯酰胺对半胱氨酸进行差异烷基化来识别质量差异。烷基化反应在相同的实验条件下进行;因此,该方法可以轻松集成到标准蛋白质组学工作流程中。使用高分辨率质谱,用人血清白蛋白的一组胰蛋白酶肽评估了该方法的可行性。解决了一些关键问题,例如标记效率以及差异烷基化对半胱氨酸肽保留和片段化的影响。根据校准曲线计算的质控样品的浓度在 ±20%可接受范围内。还证明了重标记肽与轻标记肽具有相似的提取回收率和基质效应。因此,这里提出的方法可能是稳定同位素标记策略的一种可行且具有成本效益的替代方法,可用于定量含有半胱氨酸的蛋白质。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3588/11083099/b2344c77cfec/ijms-25-04656-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验